Study to Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Participants With Schizophrenia
Clinical trial NCT03503318 · COMPLETED
Trial details
- NCT number
- NCT03503318
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-27
- Primary completion
- 2020-09-30
- Enrollment
- 544
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.